Pharming Group N.V. (PHAR)
NASDAQ·Healthcare·Biotechnology
$12.65
+0.00%
Mkt Cap $904.36M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$38.00
Range $37.00 – $40.00
Implied Upside
+200.4%
Consensus $38.00 vs current $12.65
NASDAQ·Healthcare·Biotechnology
$12.65
+0.00%
Mkt Cap $904.36M
Buy
2
Hold
0
Sell
0
Price Target (5 analysts)
$38.00
Range $37.00 – $40.00
+200.4%
Consensus $38.00 vs current $12.65